Internal Medicine, Pulmonary Disease · Westlake, OH
NPI
1275797656
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
30033 Clemens Rd
Westlake, OH, 44145
Phone (440) 899-5555
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
885 services
Medicare patients, 2024
448
Average age 75
Drug cost, 2024
$2.3M
959 prescriptions
Company payments, 2025
$4,943
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aman Pande was code 94060 (pulmonary function testing), 96 times for 96 patients. In total Aman Pande billed 885 services in 23 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94060 Pulmonary Function Testing | Office | 96 | 96 | $6.45 | $619 |
| 94729 Pulmonary Function Testing | Office | 95 | 92 | $6.14 | $583 |
| 94010 Pulmonary Function Testing | Office | 69 | 67 | $5.58 | $385 |
| 99215 Office E&M - Established | Office | 69 | 41 | $105.73 | $7,295 |
| 99215 Office E&M - Established | Facility | 67 | 47 | $100.89 | $6,759 |
| 99233 Hospital E&M - Subsequent | Facility | 62 | 47 | $86.44 | $5,359 |
| 99214 Office E&M - Established | Office | 60 | 51 | $69.57 | $4,174 |
| 99214 Office E&M - Established | Facility | 50 | 40 | $63.39 | $3,169 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 38 | 31 | $12.15 | $462 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 36 | 32 | $12.47 | $449 |
| 94726 Pulmonary Function Testing | Office | 26 | 26 | $7.91 | $206 |
| 99213 Office E&M - Established | Office | 25 | 25 | $46.56 | $1,164 |
| 99213 Office E&M - Established | Facility | 20 | 18 | $43.92 | $878 |
| 94729 Pulmonary Function Testing | Facility | 19 | 19 | $5.47 | $104 |
| 99232 Hospital E&M - Subsequent | Facility | 19 | 17 | $56.47 | $1,073 |
By year: 2022 $53K for 1,008 services; 2023 $43K for 931 services; 2024 $41K for 885 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aman Pande prescribed most often to Medicare patients was Pirfenidone, with 124 prescriptions and refills. In total Aman Pande wrote 959 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pirfenidone Generic | 124 | 124 | 16 | $448K |
| Ofev Nintedanib Esylate | 111 | 111 | 22 | $1.4M |
| Prednisone Generic | 78 | 110 | 42 | $513 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 73 | 137 | 21 | $86K |
| Mycophenolate Mofetil Generic | 72 | 112 | 20 | $9,470 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 47 | 58 | 28 | $1,536 |
| Breo Ellipta Fluticasone/Vilanterol | 46 | 64 | 14 | $25K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 36 | 47 | Under 11 | $21K |
| Spiriva Respimat Tiotropium Bromide | 25 | 39 | Under 11 | $21K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 22 | 47 | 13 | $91.11 |
| Azathioprine Generic | 20 | 22 | Under 11 | $687 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 19 | 35 | Under 11 | $2,183 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 19 | 27 | Under 11 | $5,269 |
| Advair Hfa Fluticasone Propion/Salmeterol | 18 | 29 | Under 11 | $9,353 |
| Leflunomide Generic | 17 | 31 | Under 11 | $1,123 |
Brand drugs: 484 claims; generic drugs: 475 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aman Pande $4,943 ($4,943 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $4,943.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $4,943 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.